The Latest Breaking News from Johnson & Johnson (

Months into a complex trial over their role in flooding Washington with highly addictive painkillers, the nation’s three largest opioid distributors have agreed to pay the state $518 million

An Oklahoma judge has ruled that a lawsuit can proceed that seeks reparations for survivors and descendants of victims of the 1921 Tulsa Race Massacre

Resolutions to be voted on at shareholder meeting including stopping global sales of product and racial justice audit

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 11 strange trades.

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 400 points on Tuesday.

Johnson & Johnson (NYSE: JNJ) shares are trading higher Tuesday after the company reported mixed financial results and increased its dividend.

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year

Johnson & Johnson (NYSE:JNJ) has reported Q1 FY22 adjusted earnings of $2.67 per share, up 3.1% Y/Y and ahead of the consensus of $2.61. Net sales increased 5% Y/Y (7.9% on an operational basis) to $23.43 billion, missing the consensus of $23.67 billion. Pharmaceuticals contributed $12.87 billion in sales, +9.3%, due to Darzalex…